Jenburkt Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 42.93 | 38.47 | 43.07 |
| Operating Expense | 30.19 | 28.07 | 29.79 |
| Net Profit | 8.54 | 6.51 | 9.60 |
| Net Profit Margin | 19.89 | 16.92 | 22.29 |
| Earning Per Share | 19.34 | 14.75 | 21.75 |
| EBIDTA | 13.02 | 10.40 | 13.36 |
| Effective Tax Rate | 28.10 | 28.85 | 22.59 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 42.93 |
| Operating Expense | 30.19 |
| Net Profit | 8.54 |
| Net Profit Margin | 19.89 |
| Earning Per Share | 19.34 |
| EBIDTA | 13.02 |
| Effective Tax Rate | 28.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 151.69 | 141.97 | 136.75 |
| Operating Expenses Annual | 111.30 | 108.85 | 106.38 |
| Operating Profit Annual | 47.11 | 37.79 | 35.49 |
| Interest Annual | 0.45 | 0.27 | 0.37 |
| Depreciation | 2.73 | 2.34 | 2.26 |
| Net Profit Annual | 32.06 | 25.98 | 24.61 |
| Tax Annual | 11.87 | 9.20 | 8.26 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 151.69 |
| Operating Expenses Annual | 111.30 |
| Operating Profit Annual | 47.11 |
| Interest Annual | 0.45 |
| Depreciation | 2.73 |
| Net Profit Annual | 32.06 |
| Tax Annual | 11.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 4.13 | 3.66 | 5.03 |
| Cash Flow from Operations | 27.91 | 8.12 | 17.05 |
| Cash Flow from Investing | -17.04 | -0.58 | 2.62 |
| Cash Flow from Financing | -7.62 | -7.08 | -21.04 |
| Cash Flow at the End | 7.36 | 4.13 | 3.66 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 4.13 |
| Cash Flow from Operations | 27.91 |
| Cash Flow from Investing | -17.04 |
| Cash Flow from Financing | -7.62 |
| Cash Flow at the End | 7.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 31.06 | 26.62 | 25.95 |
| PBIT Margin (%) | 29.26 | 24.97 | 24.30 |
| PBT Margin (%) | -35.75 | -67.51 | -41.40 |
| Net PROFIT Margin (%) | 21.14 | 18.30 | 18.00 |
| Return On Networth / Equity (%) | 20.25 | 19.44 | 20.53 |
| Return On Networth /Employed (%) | 27.18 | 25.67 | 26.04 |
| Return On Assets (%) | 19.66 | 18.85 | 19.26 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.04 |
| Asset Turnover Ratio (%) | 0.93 | 1.03 | 1.07 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 31.06 |
| PBIT Margin (%) | 29.26 |
| PBT Margin (%) | -35.75 |
| Net PROFIT Margin (%) | 21.14 |
| Return On Networth / Equity (%) | 20.25 |
| Return On Networth /Employed (%) | 27.18 |
| Return On Assets (%) | 19.66 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.93 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 14.66 | 10.36 | 10.45 |
| Total Current Assets Annual | 56.53 | 109.73 | 81.09 |
| Non Current Assets Annual | 139.65 | 55.37 | 60.72 |
| Total Shareholders Funds Annual | 171.78 | 144.94 | 122.39 |
| Total Assets Annual | 196.19 | 165.10 | 141.81 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 14.66 |
| Total Current Assets Annual | 56.53 |
| Non Current Assets Annual | 139.65 |
| Total Shareholders Funds Annual | 171.78 |
| Total Assets Annual | 196.19 |
No Data Availabe
